Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Head and Neck Neoplasms 1 Gastritis 1 Familial primary gastric lymphoma 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

Cisplatin 28 Radiotherapy 20 pembrolizumab 9 Paclitaxel 9 Surveys and Questionnaires 8 Cetuximab 8 Fluorouracil 7 Docetaxel 7 Radiotherapy, Intensity-Modulated 6 Carboplatin 6 apatinib 5 Low-Level Light Therapy 5 Blood Specimen Collection 5 durvalumab 4 Standard of Care 4 Magnetic Resonance Imaging 4 Gemcitabine 4 Cyclophosphamide 4 Celecoxib 4 Tegafur 3 Radiation 3 Oncolytic Virotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Lidocaine 3 Immunoenzyme Techniques 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 Biopsy 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Head and Neck Neoplasms × Amoxicillin × Clear all

NCT01598402 2013-07-15

PANTAP

Radboud University Medical Center

Phase 2/3 Unknown

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡